Develop, manufacture, and sell genomic analysis oncology diagnostics
Food and Drug Administration regulatory policy generally and policy for approval of new oncology diagnostic technologies
S. 1895 (Lower Health Care Costs Act), Section 401, regarding hospital billing practices
H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices
Reimbursement for new oncology diagnostic technologies generally, including public and private payers
H.R. 6102 (VALID Act of 2020), all provisions Medicare program policy for regulatory approval and reimbursement for new oncology diagnostic technologies 
Reimbursement for new oncology diagnostic technologies generally
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ARENTFOX SCHIFF LLP
1717 K Street, NW, Washington, DC, 20006, US
DAN RENBERG OLIVER SPURGEON III (Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009)) DAN RENBERG OLIVER SPURGEON III (Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009))
Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009) Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009)